If mother has blood type B with A antibodies and baby bloodtype How is she able to carry full term?

If the mother has blood type B with A antibodies and the baby's blood type is O, she is able to carry the baby to term because of a condition called fetomaternal alloimmunization. This occurs when the mother's immune system produces antibodies against antigens on the baby's red blood cells. In this case, the mother's A antibodies would attack the baby's A antigens. However, the baby is able to be carried to term because the placenta acts as a barrier between the mother's and baby's circulatory systems. The placenta allows oxygen and nutrients to pass from the mother to the baby, but it prevents the mother's antibodies from reaching the baby's red blood cells. Additionally, the baby's own immune system is not fully developed until after birth, so it is not able to produce antibodies against the mother's A antigens.

Here's a more detailed explanation of how it works:

The mother's blood type is B, which means that she has B antigens on her red blood cells. Her immune system also produces A antibodies, which are designed to attack A antigens.

The baby's blood type is O, which means that he/she does not have any A or B antigens on his/her red blood cells.

During pregnancy, the mother's A antibodies can cross the placenta and attack the baby's red blood cells. However, the placenta acts as a barrier and prevents the antibodies from destroying the red blood cells.

The baby's own immune system is not fully developed until after birth, so it is not able to produce antibodies against the mother's A antigens.

As a result, the baby is able to be carried to term without developing any complications from the mother's A antibodies.

It is important to note that fetomaternal alloimmunization can only occur when the mother and baby have different blood types. In this case, the mother has blood type B and the baby has blood type O, which are incompatible blood types. If the mother and baby had the same blood type, there would be no risk of fetomaternal alloimmunization.